Furosemide



Combined with:

Asa

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 25.4%
Hypertension 18.4%
Drug Use For Unknown Indication 12.7%
Cardiac Failure Congestive 6.7%
Cardiac Failure 6.6%
Cardiac Failure Chronic 6.0%
Oedema 3.8%
Oedema Peripheral 3.1%
Atrial Fibrillation 2.9%
Type 2 Diabetes Mellitus 2.6%
Diuretic Therapy 2.3%
Fluid Retention 1.6%
Diabetes Mellitus 1.6%
Prophylaxis 1.1%
Cardiac Failure Acute 1.1%
Chronic Obstructive Pulmonary Disease 1.0%
Coronary Artery Disease 0.9%
Polyuria 0.8%
Breast Cancer Metastatic 0.8%
Depression 0.8%
Renal Failure Acute 27.9%
Syncope 11.6%
Hypotension 6.4%
Renal Failure 5.4%
Hypokalaemia 5.0%
Vomiting 4.4%
Renal Impairment 4.3%
Toxic Epidermal Necrolysis 3.4%
Ventricular Tachycardia 3.3%
Drug Ineffective 3.2%
Somnolence 3.2%
Hyponatraemia 3.1%
Dehydration 2.7%
Hyperkalaemia 2.6%
Drug Interaction 2.4%
Pemphigoid 2.4%
Death 2.3%
Presyncope 2.2%
Electrocardiogram Qt Prolonged 2.1%
Torsade De Pointes 2.1%
Secondary
Product Used For Unknown Indication 37.6%
Drug Use For Unknown Indication 18.7%
Hypertension 13.8%
Cardiac Failure 4.6%
Atrial Fibrillation 2.9%
Type 2 Diabetes Mellitus 2.6%
Cardiac Failure Congestive 2.1%
Diabetes Mellitus 2.1%
Prophylaxis 1.9%
Drug Abuse 1.6%
Depression 1.5%
Ill-defined Disorder 1.5%
Oedema Peripheral 1.3%
Pain 1.3%
Cardiac Failure Chronic 1.2%
Chronic Obstructive Pulmonary Disease 1.2%
Coronary Artery Disease 1.2%
Oedema 1.1%
Pneumonia 1.0%
Diuretic Therapy 1.0%
Renal Failure Acute 17.5%
Toxic Epidermal Necrolysis 8.2%
Ventricular Tachycardia 7.5%
Vomiting 7.1%
Renal Failure 6.9%
Completed Suicide 6.1%
Hypotension 4.9%
Syncope 4.7%
Somnolence 4.3%
Hallucination 4.2%
Hyponatraemia 4.1%
Death 3.8%
Renal Impairment 3.3%
Toxicity To Various Agents 3.2%
Weight Decreased 2.7%
Weight Increased 2.5%
Drug Interaction 2.4%
Hypokalaemia 2.2%
Rhabdomyolysis 2.2%
Torsade De Pointes 2.2%
Concomitant
Product Used For Unknown Indication 31.3%
Drug Use For Unknown Indication 19.2%
Hypertension 10.6%
Prophylaxis 4.4%
Diabetes Mellitus 3.8%
Pain 3.7%
Atrial Fibrillation 3.3%
Rheumatoid Arthritis 3.1%
Cardiac Failure 2.2%
Chronic Obstructive Pulmonary Disease 2.2%
Depression 1.9%
Cardiac Disorder 1.9%
Type 2 Diabetes Mellitus 1.9%
Multiple Myeloma 1.7%
Pulmonary Arterial Hypertension 1.6%
Osteoporosis 1.6%
Constipation 1.6%
Blood Cholesterol Increased 1.5%
Gastrooesophageal Reflux Disease 1.3%
Cardiac Failure Congestive 1.2%
Vomiting 11.6%
Weight Decreased 8.2%
Weight Increased 7.6%
Death 7.6%
Renal Failure Acute 6.2%
Pneumonia 6.2%
Renal Failure 5.5%
Urinary Tract Infection 4.5%
Dyspnoea 4.3%
Thrombocytopenia 4.1%
Myocardial Infarction 3.9%
Sepsis 3.8%
Oedema Peripheral 3.5%
Pyrexia 3.5%
Nausea 3.4%
Pain 3.4%
Rhabdomyolysis 3.3%
Drug Ineffective 3.2%
Syncope 3.1%
International Normalised Ratio Increased 2.9%
Interacting
Drug Use For Unknown Indication 20.2%
Hypertension 19.9%
Product Used For Unknown Indication 18.6%
Cardiac Failure 8.9%
Atrial Fibrillation 4.4%
Hepatic Cirrhosis 4.4%
Ascites 4.2%
Ill-defined Disorder 2.3%
Prophylaxis 2.2%
Diabetes Mellitus 2.0%
Convulsion 1.7%
Type 2 Diabetes Mellitus 1.7%
Cardiac Disorder 1.4%
Cardiac Failure Congestive 1.3%
Coronary Artery Disease 1.2%
Gastritis Prophylaxis 1.1%
Oedema Peripheral 1.1%
Cerebrovascular Accident 1.1%
Hiv Infection 1.1%
Right Ventricular Failure 1.1%
Renal Failure Acute 25.6%
Drug Interaction 25.2%
Hepatic Encephalopathy 6.4%
Renal Impairment 5.1%
Hyperglycaemia 3.4%
Hyperkalaemia 3.0%
Renal Failure 3.0%
Weight Increased 3.0%
Hypotension 2.6%
Syncope 2.6%
Vomiting 2.6%
Blood Creatinine Increased 2.1%
Lactic Acidosis 2.1%
Therapeutic Agent Toxicity 2.1%
Toxicity To Various Agents 2.1%
Tremor 2.1%
Hyponatraemia 1.7%
Oedema 1.7%
Sepsis 1.7%
Tibia Fracture 1.7%